PI can partially compensate for metabolic abnormalities due to insulin resistance, e.g., by stimulating GLUT4 translocation into the cell membrane, phosphoinositol-3-phosphate increases glucose utilization in tissue cells (Unfer et al., 2017). The gene discussed is SLC2A4; the disease is Insulin resistance.